The SARS-Cov-2 pandemic: a good time for stem cell transplantation?

We read with interest the article by Arcuri et al. highlighting the importance of hematopoietic stem cell transplantation with specific conditioning regimens for aplastic anemia [1]. Allogenic hematopoietic stem cell transplantation (AHSCT) requires 4 to 6 weeks of hospitalization in the aim to prevent infectious complications. AHSCT has become a common practice in hematology centers – with for example around 15 000 allografts per year in Europe [2]. Visiting an allograft patient in a cleanroom obeys to strict hygienic measures such as washing the hands with an alcohol-based hand rub, maintaining social distancing, wearing a mask, or limiting visits to one a day [3].
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Tags: Letter to the Editor Source Type: research